Guided Superficial Enhanced Fluid Fat Injection (SEFFI) Procedures for Facial Rejuvenation: An Italian Multicenter Retrospective Case Report

• Published in: Clinics and practice 2023-08, Vol.13 (4), p.924-943
• Main Authors: Gennai, Alessandro, Baldessin, Monica, Melfa, Fabrizio, Bovani, Bruno, Camporese, Alessandra, Claysset, Barbara, Colli, Mattia, Diaspro, Alberto, Russo, Rosalba, Strano, Placido, Bollero, Daniele, Capparè, Guido, Casadei, Alessandro, Gallo, Giovanni, Piccolo, Domenico, Salti, Giovanni, Tesauro, Piero
• Format: Article
• Language: English
• Subjects: adipose-derived mesenchymal stem cells; Aging; Angiogenesis; autologous adipose tissue graft; Body fat; Case reports; clinical regeneration applications; facial rejuvenation; Hyaluronic acid; Medical equipment; Physicians; Skin; Stem cells; stromal vascular fraction; superficial enhanced fluid fat injection; Surgeons
• ISSN: 2039-7283; 2039-7275; 2039-7283
• DOI: 10.3390/clinpract13040085

Background: The aging process starts in the center of the face, in the periocular region and around the mouth, with a combination of volume loss, tissue descent, deepened wrinkles, and the loss of skin structure and quality. Recently, several studies have demonstrated the efficacy of therapies based on autologous adipose tissue grafting, which leverages the properties of stromal vascular fraction (SVF) and adipose-derived mesenchymal stem cells (ADSCs) to accelerate the regenerative processes of the skin. This study aims to verify the ability of guided superficial enhanced fluid fat injection (SEFFI) in the facial area to correct volume loss and skin aging, proving that this standardized procedure has a very low rate of complications. Methods: We retrospectively collected data from 2365 procedures performed in Italian centers between 2019 and 2021. Guided SEFFI was performed alone or combined with cosmetic treatments, including the use of hyaluronic acid filler, suspension threads, synthetic calcium hydroxylapatite, botulin toxin, and microneedling. Results: guided SEFFI was used alone in more than 60% of the patients and in all facial areas. In about one-tenth of the patients, guided SEFFI was combined with a botulin toxin treatment or hyaluronic acid filling. Other procedures were used more rarely. Ecchymosis in the donor or injection sites was the most frequent adverse event but was only observed in 14.2% and 38.6% of the patients, respectively. Conclusions: The guided SEFFI technique is standardized and minimally invasive, leading to very few complications. It constitutes a promising antiaging medical treatment that combines effectiveness, safety, and simplicity.